# Pentazocine and naloxone

NDC: 0591-0395
Generic name: Pentazocine hydrochloride and naloxone hydrochloride
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19970521

FDA application: ANDA074736

## Active ingredients

- NALOXONE HYDROCHLORIDE: .5 mg/1
- PENTAZOCINE HYDROCHLORIDE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-0395"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-0395
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a28450a0-ac93-4235-b9a6-58cdf24773cb